Development of a Buchwald–Hartwig Amination\nfor an Accelerated Library Synthesis of Cereblon Binders

In\nrecent years, targeted protein degradation (TPD) has emerged\nas a powerful therapeutic modality utilizing both heterobifunctional\nligand-directed degraders (LDDs) and molecular glues (e.g., CELMoDs)\nto recruit E3 ligases for inducing polyubiquitination and subsequent\nproteasomal degradation of target proteins. The immunomodulatory drugs\nlenalidomide and pomalidomide bind to cereblon (CRBN), a substrate\nreceptor of the CRL4A E3 ligase complex, to initiate degradation of\nneosubstrates critical for cell survival. Recently, nonlenalidomide\nor pomalidomide CRBN binders, known as alternate glutarimides, have\ngained popularity, offering potential degraders with varying physicochemical\nproperties. Specifically, 3-substituted indazole derivatives have\nemerged as potent CRBN binders. We developed conditions for the direct\ncross-coupling of unprotected glutarimides with amines, streamlining\nthe synthesis of alternative CRBN binders. This manuscript describes\nthe rapid synthesis of 30 CRBN binders, their characterization as\npotential degraders and a cryo-EM structure of the CRBN/DDB1 with\na representative compound (<b>6</b>).

Publication Details

Journal
Figshare
Published
2024-12-12
DOI
https://doi.org/10.1021/acsmedchemlett.4c00462.s001
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a Buchwald–Hartwig Amination\nfor an Accelerated Library Synthesis of Cereblon Binders

Figshare
Protein Degradation and Inhibitors
article

Development of a Buchwald–Hartwig Amination\nfor an Accelerated Library Synthesis of Cereblon Binders

article en

Abstract

In\nrecent years, targeted protein degradation (TPD) has emerged\nas a powerful therapeutic modality utilizing both heterobifunctional\nligand-directed degraders (LDDs) and molecular glues (e.g., CELMoDs)\nto recruit E3 ligases for inducing polyubiquitination and subsequent\nproteasomal degradation of target proteins. The immunomodulatory drugs\nlenalidomide and pomalidomide bind to cereblon (CRBN), a substrate\nreceptor of the CRL4A E3 ligase complex, to initiate degradation of\nneosubstrates critical for cell survival. Recently, nonlenalidomide\nor pomalidomide CRBN binders, known as alternate glutarimides, have\ngained popularity, offering potential degraders with varying physicochemical\nproperties. Specifically, 3-substituted indazole derivatives have\nemerged as potent CRBN binders. We developed conditions for the direct\ncross-coupling of unprotected glutarimides with amines, streamlining\nthe synthesis of alternative CRBN binders. This manuscript describes\nthe rapid synthesis of 30 CRBN binders, their characterization as\npotential degraders and a cryo-EM structure of the CRBN/DDB1 with\na representative compound (<b>6</b>).

Figshare
Openalex Percentile: Top 69%
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.